Risk of chemotherapy-induced febrile neutropenia in cancer patients receiving pegfilgrastim prophylaxis: does timing of administration matter?

Purpose: Contrary to the approved indication for pegfilgrastim prophylaxis, some patients receive it on the same day as the last administration of chemotherapy in clinical practice, which could adversely impact risk of febrile neutropenia (FN). An evaluation of the timing of pegfilgrastim prophylaxi...

Full description

Bibliographic Details

Published in:	Supportive Care in Cancer Vol. 24; no. 5; pp. 2309 - 2317
Main Authors:	Weycker, Derek, Li, Xiaoyan, Figueredo, Jacqueline, Barron, Rich, Tzivelekis, Spiros, Hagiwara, May
Format:	research Journal Article
Published:	Springer Nature May2016
Online Access:	View this record in EBSCOhost